Home/Filings/4/0001209191-23-034698
4//SEC Filing

Ndu Adora 4

Accession 0001209191-23-034698

CIK 0001070494other

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 9:43 PM ET

Size

7.9 KB

Accession

0001209191-23-034698

Insider Transaction Report

Form 4
Period: 2023-06-01
Ndu Adora
Director
Transactions
  • Award

    Director Stock Options (Right to Buy)

    2023-06-01+11,04511,045 total
    Exercise: $23.90Exp: 2033-06-01Common Stock (11,045 underlying)
  • Award

    Restricted Stock Units

    2023-06-01+6,6526,652 total
    Common Stock (6,652 underlying)
Footnotes (3)
  • [F1]The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Acadia common stock.
  • [F3]The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date.

Issuer

ACADIA PHARMACEUTICALS INC

CIK 0001070494

Entity typeother

Related Parties

1
  • filerCIK 0001865210

Filing Metadata

Form type
4
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 9:43 PM ET
Size
7.9 KB